Clinical Trial Update: Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease [Phase 1]

View source ↗

Summary

Phase 1 trial update investigating mobilization of stem cells in end-stage liver disease using G-CSF and Mozobil (plerixafor).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease

Drugs mentioned

• Mozobil (plerixafor)
• Neupogen (Filgrastim)

Snippet

Sponsor: Proteonomix, Inc. | Conditions: End Stage Liver DIsease | Phase 1 | Status: UNKNOWN